These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 37047329

  • 1. Mesoporous Silica Nanoparticles as a Potential Nanoplatform: Therapeutic Applications and Considerations.
    Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, Min KA.
    Int J Mol Sci; 2023 Mar 28; 24(7):. PubMed ID: 37047329
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR, Lozano D, González B, Manzano M, Izquierdo-Barba I, Vallet-Regí M.
    Expert Opin Drug Deliv; 2019 Apr 28; 16(4):415-439. PubMed ID: 30897978
    [Abstract] [Full Text] [Related]

  • 4. In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.
    Chen Y, Chen H, Shi J.
    Adv Mater; 2013 Jun 18; 25(23):3144-76. PubMed ID: 23681931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X, Chen L, Yi Z, Li C, He C, Feng C, Wang T, Shigdar S, Duan W, Kong L.
    Mini Rev Med Chem; 2018 Jun 18; 18(11):976-989. PubMed ID: 27145854
    [Abstract] [Full Text] [Related]

  • 11. A review on the latest developments of mesoporous silica nanoparticles as a promising platform for diagnosis and treatment of cancer.
    Ahmadi F, Sodagar-Taleghani A, Ebrahimnejad P, Pouya Hadipour Moghaddam S, Ebrahimnejad F, Asare-Addo K, Nokhodchi A.
    Int J Pharm; 2022 Sep 25; 625():122099. PubMed ID: 35961417
    [Abstract] [Full Text] [Related]

  • 12. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules.
    Sarkar S, Ekbal Kabir M, Kalita J, Manna P.
    Chembiochem; 2023 Apr 03; 24(7):e202200672. PubMed ID: 36719179
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C, Spoială A, Păun C, Crăciun L, Ficai D, Ficai A, Andronescu E, Turculeƫ ȘC.
    Molecules; 2020 Aug 21; 25(17):. PubMed ID: 32825791
    [Abstract] [Full Text] [Related]

  • 15. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T, Shi S, Goel S, Shen X, Xie X, Chen Z, Zhang H, Li S, Qin X, Yang H, Wu C, Liu Y.
    Acta Biomater; 2019 Apr 15; 89():1-13. PubMed ID: 30797106
    [Abstract] [Full Text] [Related]

  • 16. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
    Hosseinpour S, Walsh LJ, Xu C.
    J Mater Chem B; 2020 Nov 11; 8(43):9863-9876. PubMed ID: 33047764
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mesoporous Silica Nanoparticles as a Prospective and Promising Approach for Drug Delivery and Biomedical Applications.
    Pu X, Li J, Qiao P, Li M, Wang H, Zong L, Yuan Q, Duan S.
    Curr Cancer Drug Targets; 2019 Nov 11; 19(4):285-295. PubMed ID: 30520373
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.